Histogen to Present at the HC Wainwright 22nd Annual Global Investment Conference

SAN DIEGO, Sept. 01, 2020 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced that Richard W. Pascoe, President and Chief Executive Officer of Histogen, will present at the HC Wainwright 22nd Annual Global Investment Conference.  The virtual presentation is scheduled for Tuesday, September 15, 2020 at 11:30 a.m. Eastern Time.